Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $30,000 of TIBER CREEK HEALTH STRATEGIES INC. ON BEHALF OF ELI LILLY AND COMPANY lobbying was just disclosed

None

$30,000 of TIBER CREEK HEALTH STRATEGIES INC. ON BEHALF OF ELI LILLY AND COMPANY lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to drug pricing."

You can find more data on corporate lobbying on Quiver Quantitative.

LLY Congressional Stock Trading

Members of Congress have traded $LLY stock 13 times in the past 6 months. Of those trades, 5 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $LLY stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

LLY Insider Trading Activity

LLY Insider Trades

LLY insiders have traded $LLY stock on the open market 210 times in the past 6 months. Of those trades, 0 have been purchases and 210 have been sales.

Here’s a breakdown of recent trading of $LLY stock by insiders over the last 6 months:

  • ENDOWMENT INC LILLY has made 0 purchases and 209 sales selling 2,334,326 shares for an estimated $2,299,403,210.
  • DONALD A ZAKROWSKI (SVP, Finance, & CAO) sold 1,000 shares for an estimated $1,010,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LLY Hedge Fund Activity

We have seen 2,053 institutional investors add shares of LLY stock to their portfolio, and 1,712 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

LLY Analyst Ratings

Wall Street analysts have issued reports on $LLY in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Guggenheim issued a "Buy" rating on 01/20/2026
  • B of A Securities issued a "Buy" rating on 12/15/2025
  • Wells Fargo issued a "Overweight" rating on 12/10/2025
  • BMO Capital issued a "Outperform" rating on 12/04/2025
  • Morgan Stanley issued a "Overweight" rating on 11/24/2025
  • Bernstein issued a "Outperform" rating on 11/24/2025
  • Truist Securities issued a "Buy" rating on 11/19/2025

To track analyst ratings and price targets for LLY, check out Quiver Quantitative's $LLY forecast page.

LLY Price Targets

Multiple analysts have issued price targets for $LLY recently. We have seen 19 analysts offer price targets for $LLY in the last 6 months, with a median target of $1250.0.

Here are some recent targets:

  • Jason Gerberry from B of A Securities set a target price of $1294.0 on 04/02/2026
  • Seamus Fernandez from Guggenheim set a target price of $1163.0 on 03/30/2026
  • Rajesh Kumar from HSBC set a target price of $850.0 on 03/17/2026
  • Trung Huynh from RBC Capital set a target price of $1250.0 on 02/25/2026
  • Emily Field from Barclays set a target price of $1350.0 on 02/20/2026
  • James Shin from Deutsche Bank set a target price of $1285.0 on 02/09/2026
  • Mohit Bansal from Wells Fargo set a target price of $1280.0 on 02/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles